Algerian pharmaceutical industry fair in Addis Ababa next March

A fair dedicated to the Algerian pharmaceutical industry will be organized in March 2023 in the Ethiopian capital, Addis Ababa, in order to inquire about the various partnership opportunities offered by the African pharmaceutical industry, announced, Monday in Algiers, the CEO of the Saidal group, Fetoum Akacem.

According to a press release from the Ministry of Pharmaceutical Industry, Ms. Akacem made the announcement during the visit of Ethiopian Prime Minister Abiy Ahmed Ali to the production unit of dry forms of the Saidal Pharmaceutical Group in El Harrach (Algiers), in the presence of the Minister of Pharmaceutical Industry, Abderrahmene Djamel Lotfi Benbahmed and the Minister of Foreign Affairs and the National Community Abroad, Ramtane Lamamra.

Before the Ethiopian Chief Executive, “the CEO of the group showed the desire of all pharmaceutical operators, public or private, to strengthen and deepen bilateral cooperation in the field of the pharmaceutical industry through investments in Ethiopia for the establishment of mixed production units and the co-development of drugs,” the statement said.

To do this, it is specified, “a fair specially dedicated to the Algerian pharmaceutical industry will be organized next March in Addis Ababa to allow operators from the two countries to inquire about the various partnership opportunities that offers the continental pharmaceutical industry”

Saidal’s CEO presented to the Ethiopian Prime Minister the group’s development plan and its orientation towards “the production of high value-added pharmaceutical products derived from biotechnology, such as the production of anti-Covid vaccines. 19 ‘CoronaVac’, produced on the instructions of the President of the Republic, Abdelmadjid Tebboune, at the level of the Constantine unit from September 2021”.

“This production has allowed Algeria to reach the elitist rank of countries producing anti-Covid-19 vaccines in the world”, according to the same source.

The Saidal group “is engaged in the production of anti-cancer drugs in order to guarantee their availability for better patient care in Algeria”, adds the press release.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button